SAN DIEGO--(BUSINESS WIRE)--Dexcom, Inc., (NASDAQ:DXCM), the leader in continuous glucose monitoring (CGM), announced today that it has received U.S. Food and Drug Administration (FDA) approval for ...

Dexcom has received approval from the FDA for a new version of its smartphone connected Dexcom Share platform that will eliminate the docking cradle and allow a patient's continuous glucose monitor ...

LONDON--(BUSINESS WIRE)-- DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced both the launch of Dexcom ONE+, a CGM ...

The Julphar revolutionary real-time continuous glucose monitoring device (CGM), Dexcom G4 Platinum is now available in UAE, KSA, Kuwait and Oman and will soon be available in Qatar, Bahrain and ...

Dexcom, Inc. (NASDAQ: DXCM), wereldwijd een marktleider op het gebied van real-time continue glucosemonitoring (rt-CGM), heeft aangekondigd dat Dexcom G7 nu in Nederland rechtstreeks verbinding kan ...

Dexcom has announced it has received FDA approval of a new continuous glucose monitoring system, according to a news release. The Dexcom G4 PLATINUM system consists of three parts: a sensor, ...

Dexcom Share, a cradle device that will allow users to send data from a Dexcom continuous glucose monitor to multiple smartphones, has received 510(k) clearance from the FDA. The system is designed to ...